FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Ascend Laboratories, LLC)

View source ↗

Summary

The FDA approved a supplemental application from Ascend Laboratories, LLC for Mycophenolate mofetil (ANDA 200197).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Organ Transplant Rejection
• Systemic Lupus Erythematosus

Drugs mentioned

• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

SUPPL AP for MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)